Novel ALL treatment strategies: inotuzumab ozogamicin

Over the past year, several exciting new agents for the treatment of acute lymphoblastic leukemia (ALL) have been approved. In this interview, Elias Jabbour, MD, of the University of Texas MD Anderson... Author: VJHemOnc Added: 02/22/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts